With Nemluvio sales booming, Galderma pledges to spend $650M on US-based manufacturing
23rd October 2025 Uncategorised 0Dermatology specialist Galderma has hopped on the U.S. manufacturing bandwagon, revealing a commitment to spend more than $650 million through 2030 as it taps domestic contractors to produce newly approved Nemluvio and other skincare treatments in its portfolio.
More: With Nemluvio sales booming, Galderma pledges to spend 0M on US-based manufacturing
Source: fierce